Key Points
- McKesson EVP Francisco Fraga sold 800 shares at an average price of $995.80, generating $796,640. The Rule 10b5-1 transaction reduced his position by 12.86%, leaving him with 5,423 shares.
- McKesson recently beat quarterly expectations, reporting $9.93 in EPS and $105.38 billion in revenue, with revenue rising 7.7% year over year. The company issued fiscal 2027 EPS guidance of $44.20–$45.00.
- Analysts maintain a generally positive view, with 15 Buy ratings and four Holds producing a “Moderate Buy” consensus and an average price target of $990.35; institutional investors own 85.07% of the stock.
McKesson Corporation (NYSE:MCK - Get Free Report) EVP Francisco Fraga sold 800 shares of the stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $995.80, for a total value of $796,640.00. Following the transaction, the executive vice president owned 5,423 shares of the company's stock, valued at approximately $5,400,223.40. This trade represents a 12.86% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
McKesson Price Performance
MCK opened at $1,012.03 on Tuesday. The company has a market capitalization of $117.99 billion, a price-to-earnings ratio of 24.62, a P/E/G ratio of 2.00 and a beta of 0.30. The business's 50-day moving average price is $900.34 and its two-hundred day moving average price is $838.37. McKesson Corporation has a 1 year low of $723.68 and a 1 year high of $1,014.99.
McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, topping the consensus estimate of $9.56 by $0.37. The company had revenue of $105.38 billion during the quarter, compared to analysts' expectations of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. McKesson's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $8.26 earnings per share. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Sell-side analysts anticipate that McKesson Corporation will post 44.71 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. CWA Asset Management Group LLC boosted its holdings in McKesson by 4.8% during the 3rd quarter. CWA Asset Management Group LLC now owns 1,062 shares of the company's stock worth $907,000 after acquiring an additional 49 shares during the last quarter. Grandview Asset Management LLC grew its stake in shares of McKesson by 16.4% in the 3rd quarter. Grandview Asset Management LLC now owns 376 shares of the company's stock worth $321,000 after acquiring an additional 53 shares in the last quarter. Investment Research Partners LLC raised its holdings in shares of McKesson by 1.5% in the third quarter. Investment Research Partners LLC now owns 1,736 shares of the company's stock valued at $1,483,000 after purchasing an additional 26 shares during the last quarter. Secure Asset Management LLC raised its holdings in shares of McKesson by 6.8% in the third quarter. Secure Asset Management LLC now owns 2,267 shares of the company's stock valued at $1,935,000 after purchasing an additional 144 shares during the last quarter. Finally, Ridgecrest Wealth Partners LLC raised its holdings in shares of McKesson by 8.9% in the third quarter. Ridgecrest Wealth Partners LLC now owns 1,115 shares of the company's stock valued at $952,000 after purchasing an additional 91 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have commented on the stock. Argus raised their price target on shares of McKesson from $850.00 to $970.00 and gave the stock a "buy" rating in a report on Thursday, September 3rd. Mizuho lifted their price target on shares of McKesson from $885.00 to $905.00 in a research note on Thursday, August 6th. Morgan Stanley set a $977.00 price objective on shares of McKesson in a report on Tuesday, October 6th. TD Cowen increased their price objective on shares of McKesson from $989.00 to $1,006.00 and gave the stock a "buy" rating in a research report on Thursday, August 6th. Finally, Wells Fargo & Company raised their target price on McKesson from $812.00 to $933.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 11th. Fifteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $990.35.
Get Our Latest Analysis on MCK
About McKesson
(
Get Free Report)
McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.
McKesson's principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
